NR1D1 and type 2 diabetes mellitus: Future studies are warranted to explore mechanisms underlying increased REV-ERBα expression and transcriptional activity in human T2DM β-cell and the corresponding potential of REV-ERBα-based strategies to preserve a functional β-cell mass in T2DM.